Literature DB >> 11403104

High prevalence of vitamin D deficiency in Japanese female patients with Graves' disease.

H Yamashita1, S Noguchi, K Takatsu, E Koike, T Murakami, S Watanabe, S Uchino, H Yamashita1, H Kawamoto.   

Abstract

We reported previously that vitamin D deficiency is a causal mechanism of postoperative tetany in patients with Graves' disease. The aim of the present study was to determine the prevalence of vitamin D deficiency by reviewing serum 25(OH)D levels in 208 patients with Graves' disease (146 women, 62 men) during a 1 year period. Serum 25(OH)D levels were significantly lower (p < 0.001) in female Graves' patients (31.8 +/- 13.3 nmol/l) than in male patients (41.3 +/- 15.0 nmol/l). Vitamin D deficiency (defined as a serum 25(OH)D value below 25 nmol/l) was found in 40% of female patients and in 18% of male patients (p < 0.005). There was a significant seasonal variation in the 25(OH)D concentrations in female patients [amplitude 6.38 (95% CI, 5.42-7.56)], with values below 25 nmol/l found in 58% of female patients during the winter months. There were significant (p < 0.001) differences in serum 25(OH)D levels between age groups in the female patients. The concentrations were lowest in patients in their twenties (25.1 +/- 8.2 nmol/l) and highest in patients in their fifties and sixties (43.2 +/- 13.7 nmol/l). Serum 25(OH)D concentrations might be monitored in patients with Graves' disease during antithyroid drug therapy, and vitamin D and/or calcium supplements are recommended for patients with vitamin D deficiency.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11403104     DOI: 10.1507/endocrj.48.63

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  13 in total

1.  Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease.

Authors:  Tea Skaaby; Lise Lotte Nystrup Husemoen; Betina Heinsbæk Thuesen; Allan Linneberg
Journal:  Endocrine       Date:  2015-02-11       Impact factor: 3.633

Review 2.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

3.  Vitamin D deficiency in patients with Graves' disease: probably something more than a casual association.

Authors:  Mario Rotondi; Luca Chiovato
Journal:  Endocrine       Date:  2012-08-25       Impact factor: 3.633

4.  Vitamin D and bone metabolism in Graves' disease: a prospective study.

Authors:  S Khamisi; M Lundqvist; A J Rasmusson; B E Engström; F A Karlsson; Ö Ljunggren
Journal:  J Endocrinol Invest       Date:  2022-09-27       Impact factor: 5.467

5.  Vitamin d deficiency and its association with thyroid disease.

Authors:  Amal Mohammed Husein Mackawy; Bushra Mohammed Al-Ayed; Bashayer Mater Al-Rashidi
Journal:  Int J Health Sci (Qassim)       Date:  2013-11

6.  Vitamin D in Graves Disease: Levels, Correlation with Laboratory and Clinical Parameters, and Genetics.

Authors:  Tereza Planck; Bushra Shahida; Johan Malm; Jonas Manjer
Journal:  Eur Thyroid J       Date:  2017-11-21

7.  Intraoperative parathyroid hormone assay in patients with Graves' disease for prediction of postoperative tetany.

Authors:  Taiki Moriyama; Hiroyuki Yamashita; Shiro Noguchi; Yuji Takamatsu; Takahiro Ogawa; Shin Watanabe; Shinya Uchino; Akira Ohshima; Syoji Kuroki; Masao Tanaka
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.282

8.  Thyroid disorders and bone mineral metabolism.

Authors:  Dinesh Kumar Dhanwal
Journal:  Indian J Endocrinol Metab       Date:  2011-07

9.  Bone mineral density in patients of Graves disease pre- & post-treatment in a predominantly vitamin D deficient population.

Authors:  Viveka P Jyotsna; Abhay Sahoo; Singh Achouba Ksh; V Sreenivas; Nandita Gupta
Journal:  Indian J Med Res       Date:  2012       Impact factor: 2.375

10.  Effect of vitamin d3 on untreated graves' disease with vitamin d deficiency.

Authors:  Omar N Alhuzaim; Naji Aljohani
Journal:  Clin Med Insights Case Rep       Date:  2014-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.